Robert A. Bradway
Also at Amgen Inc
About
Robert A. Bradway is a seasoned executive with a strong foundation in both science and finance. Prior to his tenure at AMGN, he honed his expertise in the financial industry, notably serving as a Managing Director at Morgan Stanley in London from 2001, which laid the groundwork for his strategic and operational insights.
During his time at AMGN, he has consistently driven strategic growth and operational excellence through successive leadership roles. His transition from Vice President, Operations Strategy to key executive positions such as CFO, COO, President, and ultimately CEO underscores a career marked by progressive responsibility and impactful decision-making.
Beyond his direct contributions at AMGN, his involvement as a board member for prestigious companies—such as The Boeing Company—and his participation in academic and governance bodies highlight a broader commitment to corporate leadership and public policy. This multifaceted experience not only strengthens his executive profile but also reinforces his reputation as a leader who bridges the worlds of biotechnology, finance, and governance.
$AMGN Performance Under Robert A. Bradway
Past Roles
External Roles
Fixed Compensation
Performance Compensation
Performance Units (Plan-Based Awards)
Non-Equity Incentive Plan Awards (EIP/GMIP)
These details for 2023 summarize the performance compensation components awarded to Robert A. Bradway. The performance units and non-equity incentive awards are structured to align executive rewards with company financial and operational performance, incorporating strict vesting schedules, precise evaluation periods, and adjustments based on market performance (TSR modifier).